Authors:
Haim, N
Lanir, N
Hoffman, R
Haim, A
Tsalik, M
Brenner, B
Citation: N. Haim et al., Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism, AM J MED, 110(2), 2001, pp. 91-96
Authors:
Reisner, SA
Brenner, B
Haim, N
Edoute, Y
Markiewicz, W
Citation: Sa. Reisner et al., Echocardiography in nonbacterial thrombotic endocarditis: From autopsy to clinical entity, J AM S ECHO, 13(9), 2000, pp. 876-881
Citation: G. Fried et al., Clinical activity of cisplatin and prolonged oral administration of etoposide in previously treated, anthracycline-resistant, metastatic breast cancer patients: A phase II study, MED PED ONC, 34(1), 2000, pp. 10-13
Authors:
Paltiel, O
Schmit, T
Adler, B
Rachmilevitz, EA
Polliack, A
Cohen, A
Haim, N
Ben Shachar, M
Epelbaum, R
Barchana, M
Cohen, R
Ben Yehuda, D
Citation: O. Paltiel et al., The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-hodgkin lymphoma - Results and limitations of a registry-linked study, CANCER, 88(10), 2000, pp. 2357-2366
Authors:
Gez, E
Mekori, T
Struminger, L
Rubinov, R
Nativ, O
Stein, A
Haim, N
Kuten, A
Citation: E. Gez et al., T-cell subpopulation in patients with metastatic renal cell carcinoma treated by recombinant interleukin-2, recombinant interferon-alpha, 5-fluorouracil, and vinblastine, CANCER INV, 17(4), 1999, pp. 259-263
Authors:
Haim, N
Drumea, K
Epelbaum, R
Ben-Shahar, M
Citation: N. Haim et al., Dexamethasone, cytarabine, ifosfamide, and cisplatin as salvage therapy innon-Hodgkin lymphoma, AM J CL ONC, 22(1), 1999, pp. 47-50
Citation: Sd. Oman et al., Comparing two measures of creatinine clearance: an application of errors-in-variables and bootstrap techniques, J ROY STA C, 48, 1999, pp. 39-52
Authors:
Front, D
Bar-Shalom, R
Mor, M
Haim, N
Epelbaum, R
Frenkel, A
Gaitini, D
Kolodny, GM
Israel, O
Citation: D. Front et al., Hodgkin disease: Prediction of outcome with Ga-67 scintigraphy after one cycle of chemotherapy, RADIOLOGY, 210(2), 1999, pp. 487-491